<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02809859</url>
  </required_header>
  <id_info>
    <org_study_id>CIA176</org_study_id>
    <nct_id>NCT02809859</nct_id>
  </id_info>
  <brief_title>CPAP In-home Assessment USA</brief_title>
  <official_title>CPAP In-home Assessment USA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is to evaluate the product reliability, therapy effectiveness and user feedback of
      a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Existing and Na√Øve CPAP users will be recruited into a 6 month in-home study Participants
      will attend 5 study visits at day 0, 7, 30, 60 and 180. Outcome of the clinical investigation
      include downloadable device data reports, device error reports and participants perception
      questionnaires.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea Hypopnea Index (AHI), Measured as Number of Events/Hour.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Log of Safety Related Events, Measured as Number of Participants That Experienced Unacceptable Safety Related Faults</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Machine Reported Faults, Measured as Number of Patients With Machine Faults</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant Reported Faults, Measured as Number of Participant Complaints</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>How Many Participants Slept Acceptably, Well or Very Well Throughout the Night on the CPAP Device</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">139</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Investigational CPAP device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fisher &amp; Paykel Healthcare CPAP Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fisher &amp; Paykel Healthcare CPAP Device</intervention_name>
    <description>Fisher &amp; Paykel Healthcare CPAP Device</description>
    <arm_group_label>Investigational CPAP device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 22 and over

          -  Diagnosed with Obstructive Sleep Apnea (OSA) and prescribed Positive Airway Pressure
             (either Continuous positive airway pressure (CPAP) or AutoCPAP)

          -  For experienced users of PAP (CPAP or AutoCPAP) - you must be using PAP of more than 4
             hours/night for 70% during the last 30 days.

        Exclusion Criteria:

          -  Contraindicated for PAP (CPAP or AutoCPAP) therapy

          -  Has other significant sleep disorders (e.g periodic leg movements, insomnia, central
             sleep apnea)

          -  Has obesity hypoventilation syndrome or congestive heart failure

          -  Requires supplemental oxygen with their PAP (CPAP or AutoCPAP) device

          -  Has implanted electronic medical devices (e.g cardiac pacemakers)

          -  Pregnant or think they may be pregnant

          -  Not fluent in spoken and written English.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matt Uhles</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clayton Sleep Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alabama Sleep Clinic</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonary Disease Specialists - Central Florida Sleep Centre</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clayton Sleep Institute</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio Sleep Medicine and Neurosciences Institute</name>
      <address>
        <city>Dublin</city>
        <state>Ohio</state>
        <zip>43017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>June 19, 2016</study_first_submitted>
  <study_first_submitted_qc>June 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2016</study_first_posted>
  <results_first_submitted>October 8, 2018</results_first_submitted>
  <results_first_submitted_qc>February 12, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">March 5, 2019</results_first_posted>
  <last_update_submitted>February 12, 2019</last_update_submitted>
  <last_update_submitted_qc>February 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 21, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT02809859/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Investigational CPAP Device</title>
          <description>Fisher &amp; Paykel Healthcare CPAP Device
Fisher &amp; Paykel Healthcare CPAP Device: Fisher &amp; Paykel Healthcare CPAP Device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="139"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Investigational CPAP Device</title>
          <description>Fisher &amp; Paykel Healthcare CPAP Device
Fisher &amp; Paykel Healthcare CPAP Device: Fisher &amp; Paykel Healthcare CPAP Device</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="139"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Age wasn't provided by one of the participants</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="138"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.5" lower_limit="29" upper_limit="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Apnea Hypopnea Index (AHI), Measured as Number of Events/Hour.</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Investigational CPAP Device</title>
            <description>Fisher &amp; Paykel Healthcare CPAP Device
Fisher &amp; Paykel Healthcare CPAP Device: Fisher &amp; Paykel Healthcare CPAP Device</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea Hypopnea Index (AHI), Measured as Number of Events/Hour.</title>
          <units>events/hr</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Log of Safety Related Events, Measured as Number of Participants That Experienced Unacceptable Safety Related Faults</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Investigational CPAP Device</title>
            <description>Fisher &amp; Paykel Healthcare CPAP Device
Fisher &amp; Paykel Healthcare CPAP Device: Fisher &amp; Paykel Healthcare CPAP Device</description>
          </group>
        </group_list>
        <measure>
          <title>Log of Safety Related Events, Measured as Number of Participants That Experienced Unacceptable Safety Related Faults</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Machine Reported Faults, Measured as Number of Patients With Machine Faults</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Investigational CPAP Device</title>
            <description>Fisher &amp; Paykel Healthcare CPAP Device
Fisher &amp; Paykel Healthcare CPAP Device: Fisher &amp; Paykel Healthcare CPAP Device</description>
          </group>
        </group_list>
        <measure>
          <title>Machine Reported Faults, Measured as Number of Patients With Machine Faults</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Participant Reported Faults, Measured as Number of Participant Complaints</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Investigational CPAP Device</title>
            <description>Fisher &amp; Paykel Healthcare CPAP Device
Fisher &amp; Paykel Healthcare CPAP Device: Fisher &amp; Paykel Healthcare CPAP Device</description>
          </group>
        </group_list>
        <measure>
          <title>Participant Reported Faults, Measured as Number of Participant Complaints</title>
          <units>complaints</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>How Many Participants Slept Acceptably, Well or Very Well Throughout the Night on the CPAP Device</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Investigational CPAP Device</title>
            <description>Fisher &amp; Paykel Healthcare CPAP Device
Fisher &amp; Paykel Healthcare CPAP Device: Fisher &amp; Paykel Healthcare CPAP Device</description>
          </group>
        </group_list>
        <measure>
          <title>How Many Participants Slept Acceptably, Well or Very Well Throughout the Night on the CPAP Device</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected during the study period of each participant (i.e. 6 months)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Investigational CPAP Device</title>
          <description>Fisher &amp; Paykel Healthcare CPAP Device
Fisher &amp; Paykel Healthcare CPAP Device: Fisher &amp; Paykel Healthcare CPAP Device</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="139"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="139"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <description>Atrial Fibrillation assessed to be unrelated to trial</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="139"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Community acquired pneumonia</sub_title>
                <description>Community acquired pneumonia assessed to be unrelated to trial</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="139"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="139"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Scientist</name_or_title>
      <organization>Fisher &amp; Paykel Healthcare</organization>
      <phone>+64 9 574 0123 ext 7044</phone>
      <email>CPAP.TRIAL@fphcare.co.nz</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

